Vsee Health (VSEEW) EBIT (2022 - 2026)
On a quarterly basis, EBIT fell 62.41% to -$3.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$10.7 million, a 82.99% increase, with the full-year FY2025 number at -$9.6 million, up 84.58% from a year prior.
Vsee Health's EBIT history spans 5 years, with the latest figure at -$3.0 million for Q1 2026.
- EBIT came in at -$3.0 million for Q1 2026, up from -$3.4 million in the prior quarter.
- The five-year high for EBIT was $104060.0 in Q1 2024, with the low at -$58.3 million in Q3 2024.
- Historically, EBIT has averaged -$5.0 million across 5 years, with a median of -$1.2 million in 2022.
- Peak annual rise in EBIT hit 114.54% in 2024, while the deepest fall reached 16411.08% in 2024.
- Year by year, EBIT stood at -$1.2 million in 2022, then skyrocketed by 90.43% to -$114831.0 in 2023, then plummeted by 2536.38% to -$3.0 million in 2024, then decreased by 13.61% to -$3.4 million in 2025, then grew by 13.52% to -$3.0 million in 2026.
- Business Quant data shows EBIT for VSEEW at -$3.0 million in Q1 2026, -$3.4 million in Q4 2025, and -$2.1 million in Q3 2025.
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.97 Mn |
| Dec 31, 2025 | 3.07 Mn |
| Sep 30, 2025 | -2.06 Mn |
| Jun 30, 2025 | -2.25 Mn |
| Mar 31, 2025 | -1.83 Mn |
| Dec 31, 2024 | -3.03 Mn |
| Sep 30, 2024 | -58.29 Mn |
| Mar 31, 2024 | 104,060.00 |
| Dec 31, 2023 | -114,831.00 |
| Sep 30, 2023 | -353,066.00 |
| Jun 30, 2023 | -689,837.00 |
| Mar 31, 2023 | -715,855.00 |
| Dec 31, 2022 | -1.20 Mn |
| Sep 30, 2022 | -1.13 Mn |
| Jun 30, 2022 | -722,162.00 |
| Mar 31, 2022 | -543,179.00 |